The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population - 24/07/21
Doi : 10.1016/j.jinf.2021.05.022
Andreas Stang, MD, MPH a, ⁎ 
, Johannes Robers, MTA b , Birte Schonert, MTA c , Karl-Heinz Jöckel, PhD d , Angela Spelsberg, MD, SM e , Ulrich Keil, MD, PhD f , Paul Cullen, MD, MSc g
, Johannes Robers, MTA b , Birte Schonert, MTA c , Karl-Heinz Jöckel, PhD d , Angela Spelsberg, MD, SM e , Ulrich Keil, MD, PhD f , Paul Cullen, MD, MSc g a Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany; School of Public Health, Department of Epidemiology, Boston University, Boston, USA
b MVZ Labor Münster Hafenweg GmbH, Hafenweg 9-11; 48155, Münster, Germany
c MVZ Labor Münster Hafenweg GmbH, Hafenweg 9-11; 48155 Münster, Germany
d Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany
e Tumorzentrum Aachen e.V., Pauwelsstraße 30, 52074 Aachen, Germany
f Institute of Epidemiology and Social Medicine, University of Münster, Albert Schweitzer Campus 1, 48149 Münster
g MVZ Labor Münster Hafenweg GmbH, Hafenweg 9-11; 48155, Münster, Germany
⁎Corresponding author: Prof. Andreas Stang, MD, MPH, Institut für Medizinische Informatik, Biometrie und Epidemiologie, Universitätsklinikum Essen, Germany. Tel.: +49 201 723 77 201; fax: +49 201 723 77 333Institut für Medizinische Informatik, Biometrie und EpidemiologieUniversitätsklinikum EssenGermany
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Covid-19, SARS-CoV-2 real time-polymerase chain reaction, cycle-threshold value, infectious potential, laboratory quality assurance, screening
Le texte complet de cet article est disponible en PDF.
© 2021
Elsevier Ltd. Tous droits réservés.
Vol 83 - N° 2
P. 237-279 - août 2021 Retour au numéro
Article précédent
- One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG
- Amedeo F. Capetti, Fabio Borgonovo, Davide Mileto, Gloria Gagliardi, Chiara Mariani, Angelica Lupo, Gianfranco Dedivitiis, Paola Meraviglia, Martina Pellicciotta, Luciana Armiento, Maria V. Cossu, Giuliano Rizzardini
- Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
- Adeel A. Butt, Tasnim Khan, Peng Yan, Obaid S. Shaikh, Saad B. Omer, Florian Mayr
Bienvenue sur EM-consulte, la référence des professionnels de santé.